Degenerative joint diseases that ultimately lead to osteoarthritis considerably reduce the quality of life of sufferers. FORTIGEL® specifically stimulates cartilage cells and enhances the synthesis of cartilage tissue. In this way FORTIGEL® is a new and promising agent for counteracting the progressive loss of

joint cartilage by actually fighting the cause rather than only targeting the symptoms of the problem. After simple pain-killers and chondroitin/glucosamine, which at best only affect 25% of the cartilage, FORTIGEL® could well be called “The Third Generation of Joint Care”.

This revolutionary effect of FORTIGEL® has been confirmed in numerous international preclinical and clinical studies conducted by independent and renowned research institutes, e.g. the Collagen Research Institute (CRI), Kiel, Germany.

To demonstrate how easily FORTIGEL® can be formulated in a wide range of products from liquid or solid dietary supplements to enriched foods, GELITA will provide a number

of prototypes and application concepts for tasting at HIE in Paris. For its exemplary achievements in the promotion of consumer health, GELITA has won the Frost & Sullivan Ingredient of The Year Award 2008 with FORTIGEL®.

Innovative, if unconventional, ideas are important

GELITA develops new, sometimes unconventional, product ideas for its customers, such as low-fat/low-calorie chocolate, fortified beverages, fat-reduced soft ice cream, to mention just a few. For this, GELITA has a creative and capable R&D and Product Development team, always craving for new challenges.

Visit GELITA booth E018 at HI Europe on November 4 - 6, 2008 in Paris and see how your product range can benefit from the outstanding properties of the functional ingredients and the new product ideas from GELITA.